We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
69 hedge funds and large institutions have $332M invested in State Street SPDR S&P Pharmaceuticals ETF in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
20% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 20
16% more capital invested
Capital invested by funds: $287M → $332M (+$45.5M)
6.5% more ownership
Funds ownership: 63.93% → 70.43% (+6.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 72 → 69 (-3)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
Holders
69
Holders Change
-3
Holders Change %
-4.17%
% of All Funds
1.98%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
10
Increased
24
Reduced
20
Closed
13
Calls
$218K
Puts
–
Net Calls
+$218K
Net Calls Change
+$218K
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$30.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.6M |
| 3 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
+$4.51M |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$1.97M |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$1.92M |
Top Sellers
| 1 |
PFG
Pacific Financial Group
Bellevue,
Washington
|
-$4.99M |
| 2 |
Citigroup
New York
|
-$4.83M |
| 3 |
Morgan Stanley
New York
|
-$4.41M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.87M |
| 5 |
Jane Street
New York
|
-$3.69M |
